Nucleofection: A New Method for Cutaneous Gene Transfer?
Open Access
- 1 January 2006
- journal article
- other
- Published by Wiley in BioMed Research International
- Vol. 2006 (1) , 26060
Abstract
Background. Transfection efficacy after nonviral gene transfer in primary epithelial cells is limited. The aim of this study was to compare transfection efficacy of the recently available method of nucleofection with the established transfection reagent FuGENE6. Methods. Primary human keratinocytes (HKC), primary human fibroblasts (HFB), and a human keratinocyte cell line (HaCaT) were transfected with reporter gene construct by FuGENE6 or Amaxa Nucleofector device. At corresponding time points, β‐galactosidase expression, cell proliferation (MTT‐Test), transduction efficiency (X‐gal staining), cell morphology, and cytotoxicity (CASY) were determined. Results. Transgene expression after nucleofection was significantly higher in HKC and HFB and detected earlier (3 h vs. 24 h) than in FuGENE6. After lipofection 80%–90% of the cells remained proliferative without any influence on cell morphology. In contrast, nucleofection led to a decrease in keratinocyte cell size, with only 20%–42% proliferative cells. Conclusion. Related to the method‐dependent increase of cytotoxicity, transgene expression after nucleofection was earlier and higher than after lipofection.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (Ste 1099)
- Ruhr-Universität Bochum (Ste 1099)
This publication has 32 references indexed in Scilit:
- Polybrene improves transfection efficacy of recombinant replication‐deficient adenovirus in cutaneous cells and burned skinThe Journal of Gene Medicine, 2005
- Gene therapy and the skinAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2004
- TGF-β/Smad signaling inhibits IFN-γ and TNF-α-induced TARC (CCL17) production in HaCaT cellsJournal of Dermatological Science, 2003
- Gene Therapy Progress and Prospects: Nonviral vectorsGene Therapy, 2002
- The Epidermis as a Bioreactor: Topically Regulated Cutaneous Delivery into the CirculationHuman Gene Therapy, 2002
- Virus-Based Gene Delivery SystemsClinical Pharmacokinetics, 2002
- Cutaneous gene transfer and therapy: the present and the futureThe Journal of Gene Medicine, 2001
- Regulated Cutaneous Gene Delivery: The Skin as a BioreactorHuman Gene Therapy, 2000
- Genetic Correction of Inherited Epidermal DisordersHuman Gene Therapy, 2000
- Stable integration of large (>100 kb) PAC constructs in HaCaT keratinocytes using an integrin-targeting peptide delivery systemGene Therapy, 2000